المؤلفون: Kim JO; Department of Oncology, Division of Radiation Oncology †Department of Oncology, Division of Medical Oncology ‡Division of Medical Physics, Department of Oncology, University of Alberta & Cross Cancer Institute, Edmonton, AB, Canada., Chu KP, Fairchild A, Ghosh S, Butts C, Chu Q, Gabos Z, Joy AA, Nijjar T, Robinson DM, Sangha R, Scrimger R, Smylie M, Yee D, Roa WH

المصدر: American journal of clinical oncology [Am J Clin Oncol] 2017 Jun; Vol. 40 (3), pp. 294-299.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*therapy , Lung Neoplasms/*therapy , Radiotherapy, Intensity-Modulated/*methods, Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/diagnostic imaging ; Chemoradiotherapy/adverse effects ; Cisplatin/administration & dosage ; Disease-Free Survival ; Etoposide/administration & dosage ; Female ; Humans ; Lung Neoplasms/diagnostic imaging ; Male ; Middle Aged ; Prospective Studies ; Radiation Dose Hypofractionation ; Radiotherapy, Intensity-Modulated/adverse effects ; Response Evaluation Criteria in Solid Tumors ; Survival Rate ; Tomography, X-Ray Computed